| The role of apoptosis, proliferation, and the Bcl-2–related proteins in the myelodysplastic syndromes and acute myeloid leukemia secondary to MDS JE Parker, GJ Mufti, F Rasool, A Mijovic, S Devereux, A Pagliuca Blood, The Journal of the American Society of Hematology 96 (12), 3932-3938, 2000 | 481 | 2000 |
| Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood … M Mohty, F Malard, M Abecassis, E Aerts, AS Alaskar, M Aljurf, M Arat, ... Bone marrow transplantation 51 (7), 906-912, 2016 | 426 | 2016 |
| Prevalence of the activating JAK2 tyrosine kinase mutation V617F in the Budd–Chiari syndrome RK Patel, NC Lea, MA Heneghan, NB Westwood, D Milojkovic, ... Gastroenterology 130 (7), 2031-2038, 2006 | 330 | 2006 |
| BCSH/BSBMT guideline: diagnosis and management of veno‐occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation FL Dignan, RF Wynn, N Hadzic, J Karani, A Quaglia, A Pagliuca, P Veys, ... British journal of haematology 163 (4), 444-457, 2013 | 325 | 2013 |
| Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and … S Corbacioglu, E Carreras, M Ansari, A Balduzzi, S Cesaro, JH Dalle, ... Bone marrow transplantation 53 (2), 138-145, 2018 | 294 | 2018 |
| Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem‐cell transplantation DI Marks, A Pagliuca, CC Kibbler, A Glasmacher, CP Heussel, M Kantecki, ... British journal of haematology 155 (3), 318-327, 2011 | 279 | 2011 |
| Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies R Benjamin, C Graham, D Yallop, A Jozwik, OC Mirci-Danicar, G Lucchini, ... The Lancet 396 (10266), 1885-1894, 2020 | 258 | 2020 |
| COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA) L Pagano, J Salmanton-García, F Marchesi, A Busca, P Corradini, ... Journal of hematology & oncology 14 (1), 168, 2021 | 248 | 2021 |
| Reduced-intensity allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia with multilineage dysplasia using fludarabine … AYL Ho, A Pagliuca, M Kenyon, JE Parker, A Mijovic, S Devereux, ... Blood 104 (6), 1616-1623, 2004 | 244 | 2004 |
| BEAM-alemtuzumab reduced-intensity allogeneic stem cell transplantation for lymphoproliferative diseases: GVHD, toxicity, and survival in 65 patients RD Faulkner, C Craddock, JL Byrne, P Mahendra, AP Haynes, ... Blood 103 (2), 428-434, 2004 | 217 | 2004 |
| Alemtuzumab with fludarabine and cyclophosphamide reduces chronic graft-versus-host disease after allogeneic stem cell transplantation for acquired aplastic anemia JC Marsh, V Gupta, ZY Lim, AY Ho, RM Ireland, J Hayden, V Potter, ... Blood, The Journal of the American Society of Hematology 118 (8), 2351-2357, 2011 | 191 | 2011 |
| Nonmyeloablative stem cell transplantation for congenital immunodeficiencies P Amrolia, HB Gaspar, A Hassan, D Webb, A Jones, N Sturt, ... Blood, The Journal of the American Society of Hematology 96 (4), 1239-1246, 2000 | 191 | 2000 |
| ‘Low‐risk’myelodysplastic syndrome is associated with excessive apoptosis and an increased ratio of pro‐versus anti‐apoptotic bcl‐2‐related proteins Fishlock, Mijovic, Czepulkowski, Pagliuca, Mufti British journal of haematology 103 (4), 1075-1082, 1998 | 171 | 1998 |
| Fludarabine, cytarabine, G‐CSF and idarubicin (FLAG‐IDA) for the treatment of poor‐risk myelodysplastic syndromes and acute myeloid leukaemia JE Parker, A Pagliuca, A Mijovic, JO Cullis, B Czepulkowski, ... British journal of haematology 99 (4), 939-944, 1997 | 171 | 1997 |
| Peripheral blood but not tissue dendritic cells express CD52 and are depleted by treatment with alemtuzumab AGS Buggins, GJ Mufti, J Salisbury, J Codd, N Westwood, M Arno, ... Blood, The Journal of the American Society of Hematology 100 (5), 1715-1720, 2002 | 166 | 2002 |
| Outcomes of allogeneic hematopoietic cell transplantation in patients with myelofibrosis with prior exposure to Janus kinase 1/2 inhibitors M Shanavas, U Popat, LC Michaelis, V Fauble, D McLornan, R Klisovic, ... Biology of Blood and Marrow Transplantation 22 (3), 432-440, 2016 | 165 | 2016 |
| Retrospective comparison of bone marrow and granulocyte colony-stimulating factor–mobilized peripheral blood progenitor cells for allogeneic stem cell transplantation using HLA … P Guardiola, V Runde, A Bacigalupo, T Ruutu, F Locatelli, MA Boogaerts, ... Blood, The Journal of the American Society of Hematology 99 (12), 4370-4378, 2002 | 164 | 2002 |
| Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines M Mikulska, D Averbuch, F Tissot, C Cordonnier, M Akova, T Calandra, ... Journal of Infection 76 (1), 20-37, 2018 | 159 | 2018 |
| Peripheral blood hematopoietic stem cells for transplantation of hematological diseases from related, haploidentical donors after reduced-intensity conditioning K Raj, A Pagliuca, K Bradstock, V Noriega, V Potter, M Streetly, ... Biology of Blood and Marrow Transplantation 20 (6), 890-895, 2014 | 155 | 2014 |
| Treatment of CD40 ligand deficiency by hematopoietic stem cell transplantation: a survey of the European experience, 1993-2002 AR Gennery, K Khawaja, P Veys, RGM Bredius, LD Notarangelo, ... Blood 103 (3), 1152-1157, 2004 | 152 | 2004 |
